{
    "title": "First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening",
    "abstract": "Background Down's syndrome occurs when a person has three copies of chromosome 21 (or the specific area of chromosome 21 implicated in causing Down's syndrome) rather than two. It is the commonest congenital cause of mental disability. Non\u2010invasive screening based on biochemical analysis of maternal serum or urine, or fetal ultrasound measurements, allows estimates of the risk of a pregnancy being affected and provides information to guide decisions about definitive testing. \u00a0  Before agreeing to screening tests, parents need to be fully informed about the risks, benefits and possible consequences of such a test. This includes subsequent choices for further tests they may face, and the implications of both false positive (i.e. invasive diagnostic testing, and the possibility that a miscarried fetus may be chromosomally normal) and false negative screening tests (i.e. a fetus with Down\u2019s syndrome will be missed). The decisions that may be faced by expectant parents inevitably engender a high level of anxiety at all stages of the screening process, and the outcomes of screening can be associated with considerable physical and psychological morbidity. No screening test can predict the severity of problems a person with Down's syndrome will have.    Objectives To estimate and compare the accuracy of first and second trimester serum markers with and without first trimester ultrasound markers for the detection of Down\u2019s syndrome in the antenatal period, as combinations of markers.    Search methods We conducted a sensitive and comprehensive literature search of MEDLINE (1980 to 25 August 2011), Embase (1980 to 25 August 2011), BIOSIS via EDINA (1985 to 25 August 2011), CINAHL via OVID (1982 to 25 August 2011), the Database of Abstracts of Reviews of Effectiveness (the Cochrane Library 25 August 2011), MEDION (25 August 2011), the Database of Systematic Reviews and Meta\u2010Analyses in Laboratory Medicine (25 August 2011), the National Research Register (Archived 2007), and Health Services Research Projects in Progress database (25 August 2011). We did not apply a diagnostic test search filter. We did forward citation searching in ISI citation indices, Google Scholar and PubMed \u2018related articles\u2019. We also searched reference lists of retrieved articles    Selection criteria Studies evaluating tests of combining first and second trimester maternal serum markers in women up to 24 weeks of gestation for Down's syndrome, with or without first trimester ultrasound markers, compared with a reference standard, either chromosomal verification or macroscopic postnatal inspection.    Data collection and analysis Data were extracted as test positive/test negative results for Down's and non\u2010Down's pregnancies allowing estimation of detection rates (sensitivity) and false positive rates (1\u2010specificity). We performed quality assessment according to QUADAS criteria. We used hierarchical summary ROC meta\u2010analytical methods to analyse test performance and compare test accuracy. Analysis of studies allowing direct comparison between tests was undertaken. We investigated the impact of maternal age on test performance in subgroup analyses.    Main results Twenty\u2010two studies (reported in 25 publications) involving 228,615 pregnancies (including 1067 with Down's syndrome) were included. Studies were generally high quality, although differential verification was common with invasive testing of only high risk pregnancies. Ten studies made direct comparisons between tests. Thirty\u2010two different test combinations were evaluated formed from combinations of eight different tests and maternal age; first trimester nuchal translucency (NT) and the serum markers AFP, uE3, total hCG, free \u03b2hCG, Inhibin A, PAPP\u2010A and ADAM 12. We looked at tests combining first and second trimester markers with or without ultrasound as complete tests, and we also examined stepwise and contingent strategies.  Meta\u2010analysis of the six most frequently evaluated test combinations showed that a test strategy involving maternal age and a combination of first trimester NT and PAPP\u2010A, and second trimester total hCG, uE3, AFP and Inhibin A significantly outperformed other test combinations that involved only one serum marker or NT in the first trimester, detecting about nine out of every 10 Down's syndrome pregnancies at a 5% false positive rate. However, the evidence was limited in terms of the number of studies evaluating this strategy, and we therefore cannot recommend one single screening strategy.    Authors' conclusions Tests involving first trimester ultrasound with first and second trimester serum markers in combination with maternal age are significantly better than those without ultrasound, or those evaluating first trimester ultrasound in combination with second trimester serum markers, without first trimester serum markers. We cannot make recommendations about a specific strategy on the basis of the small number of studies available.",
    "review_type": "Diagnostic",
    "doi": "https://doi.org/10.1002/14651858.CD012599",
    "review_id": "CD012599",
    "criteria": {
        "Types of studies": "We included studies in which all women from a given population had one or more index test(s) compared to a reference standard. Both consecutive series and diagnostic case\u2010control study designs were included. Randomised trials where individuals were randomised to different screening strategies and all verified using a reference standard were also eligible for inclusion. Studies in which test strategies were compared head\u2010to\u2010head either in the same women, or between randomised groups were identified for inclusion in separate comparisons of test strategies. Studies were excluded if they included less than five Down's syndrome cases, or more than 20% of participants were not followed up.",
        "Participants": "Pregnant women up to 24 weeks' gestation confirmed by ultrasound, who had not undergone previous testing for Down\u2019s syndrome in their pregnancy were eligible. Studies were included if the pregnant women were unselected, or if they represented groups with increased risk of Down\u2019s syndrome, or difficulty with conventional screening tests including maternal age greater than 35 years old, multiple pregnancy, diabetes mellitus and family history of Down\u2019s syndrome.",
        "Index tests": "The following index tests were examined; nuchal translucency (NT) scanning, ADAM12, AFP, uE3,total hCG, free \u03b2hCG, Inhibin A, PAPP\u2010A, and combinations of these markers with maternal age. Combinations without maternal age were excluded. We looked at comparisons of tests in isolation and in various combinations. All strategies included first and second trimester serum tests, and some included additional first trimester ultrasound markers. The maximum number of markers in any one test was seven, in combination with maternal age. Where tests were used in comparison we looked at the performance of test comparisons according to predicted probabilities computed using risk equations and dichotomised into high risk and low risk (and medium risk, where applicable).",
        "Target conditions": "Down's syndrome in the fetus due to trisomy, translocation or mosaicism.",
        "Reference standards": "We considered several reference standards, involving chromosomal verification and postnatal macroscopic inspection. Amniocentesis and chorionic villus sampling (CVS) are invasive chromosomal verification tests undertaken during pregnancy. They are highly accurate, but the process carries a 1% miscarriage rate, and therefore they are only used in pregnancies considered to be at high risk of Down's, or at the mother's request. All other types of testing (postnatal examination, postnatal karyotyping, birth registers and Down\u2019s syndrome registers) are based on information available at the end of pregnancy. The greatest concern is not their accuracy, but the loss of the pregnancy to miscarriage between the serum test and the reference standard. Miscarriage with cytogenetic testing of the fetus is included in the reference standard where available. We anticipated that older studies, and studies undertaken in older women are more likely to have used invasive chromosomal verification tests in all women. Studies undertaken in younger women and more recent studies were likely to use differential verification as they often only used prenatal karyotypic testing on fetuses considered screen positive/high risk according to the screening test; the reference standard for most unaffected infants being observing a phenotypically normal baby. Although the accuracy of this combined reference standard is considered high, it is methodologically a weaker approach as pregnancies that miscarry between the index test and birth are likely to be lost from the analysis, and miscarriage is more likely to occur in Down's than normal pregnancies. We investigated the impact of the likely missing false negative results in sensitivity analyses."
    },
    "search_strategy": {
        "Appendix 1. Search Strategy": "Database: Ovid MEDLINE \u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010 1\u00a0\u00a0\u00a0 \u00a0exp Prenatal Diagnosis/ 2\u00a0 \u00a0\u00a0\u00a0nuchal translucency.mp. 3\u00a0\u00a0\u00a0\u00a0 exp Pregnancy\u2010Associated Plasma Protein\u2010A/ 4\u00a0\u00a0\u00a0\u00a0 pregnancy associated plasma protein a.mp. 5\u00a0\u00a0\u00a0\u00a0 papp\u2010a.mp. 6\u00a0\u00a0\u00a0\u00a0 exp Chorionic Gonadotropin, beta Subunit, Human/ 7\u00a0\u00a0\u00a0\u00a0 (b\u2010hcg or bhcg).mp. 8\u00a0\u00a0\u00a0\u00a0 human chorionic gonadotropin.mp. 9\u00a0\u00a0\u00a0 \u00a0exp alpha\u2010Fetoproteins/ 10\u00a0\u00a0\u00a0\u00a0 alphafetoprotein$.mp. 11\u00a0\u00a0\u00a0\u00a0 alpha\u2010fetoprotein$.mp. 12\u00a0\u00a0\u00a0\u00a0 afp.mp. 13\u00a0\u00a0\u00a0\u00a0 (unconjugated estriol or unconjugated oestriol).mp. 14\u00a0\u00a0\u00a0\u00a0 ue3.mp. 15\u00a0\u00a0\u00a0\u00a0 exp INHIBINS/ 16\u00a0\u00a0\u00a0\u00a0 inhibin a.mp. 17\u00a0\u00a0\u00a0\u00a0 ultrasound.mp. 18\u00a0\u00a0\u00a0\u00a0 amniocentesis/ 19\u00a0\u00a0\u00a0\u00a0 chorion$ vill$ sampling.mp. 20\u00a0\u00a0\u00a0\u00a0 Chorionic Villi\u2010Sampling/ 21\u00a0\u00a0\u00a0\u00a0 nasal bone.mp. 22\u00a0 \u00a0\u00a0\u00a0tricuspid regurgitation.mp. 23\u00a0\u00a0\u00a0\u00a0 ductus venosus.mp 24\u00a0\u00a0\u00a0\u00a0 marker$.mp. 25\u00a0\u00a0\u00a0\u00a0 screen$.mp. 26\u00a0\u00a0\u00a0\u00a0 detect$.mp. 27\u00a0\u00a0\u00a0\u00a0 accura$.mp. 28\u00a0\u00a0\u00a0\u00a0 predict$.mp. 29\u00a0\u00a0\u00a0\u00a0 ROC.mp. 30 \u00a0\u00a0\u00a0\u00a0ROC curve/ 31\u00a0\u00a0\u00a0\u00a0 AUC.mp. 32\u00a0\u00a0\u00a0\u00a0 Area under curve/ 33\u00a0\u00a0\u00a0\u00a0 exp false negative reactions/ or exp false positive reactions/ 34\u00a0\u00a0\u00a0\u00a0 (false positive$ or false negative$).mp. 35 \u00a0\u00a0\u00a0\u00a0likelihood ratio$.mp. 36\u00a0\u00a0\u00a0\u00a0 sensitiv$.mp. 37\u00a0\u00a0\u00a0\u00a0 specific$.mp. 38\u00a0\u00a0\u00a0\u00a0 diagnos$.ti,ab. 39\u00a0\u00a0\u00a0\u00a0 \"reproducibility of results\".mp. 40\u00a0\u00a0\u00a0\u00a0 reference value$.mp. 41\u00a0\u00a0\u00a0\u00a0 reference standard$.mp. 42\u00a0\u00a0\u00a0\u00a0 exp Down Syndrome/ 43\u00a0\u00a0\u00a0\u00a0 downs syndrome.mp. 44\u00a0\u00a0\u00a0\u00a0 down syndrome.mp. 45\u00a0\u00a0\u00a0\u00a0 trisomy 21.mp. 46\u00a0\u00a0\u00a0\u00a0 Aneuploidy/ 47\u00a0\u00a0\u00a0\u00a0 aneuploidy.mp. 48\u00a0\u00a0\u00a0\u00a0 Mosaicism/ 49\u00a0\u00a0\u00a0\u00a0 mosaicism.mp. 50\u00a0\u00a0\u00a0\u00a0 or/1\u201041 51\u00a0\u00a0\u00a0\u00a0 or/42\u201049 52\u00a0\u00a0\u00a0\u00a0 50 and 51 53\u00a0\u00a0\u00a0\u00a0 (antenatal$ or prenatal$ or trimester$ or pregnan$ or fetus or foetus or fetal or foetal).mp.  54\u00a0\u00a0\u00a0\u00a0 52 and 53 55\u00a0\u00a0\u00a0\u00a0 animal/ not (humans/ and animal/) 56\u00a0\u00a0\u00a0\u00a0 54 not 55 ******************************************************* EMBASE via Dialog Datastar \u00a0 1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PRENATAL\u2010DIAGNOSIS#.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 FETUS\u2010ECHOGRAPHY#.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PREGNANCY\u2010ASSOCIATED\u2010PLASMA\u2010PROTEIN\u2010A#.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CHORIONIC\u2010GONADOTROPIN\u2010BETA\u2010SUBUNIT#.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 HCG.AB.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PAPP.AB.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ALPHA\u2010FETOPROTEIN#.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 AFP.AB.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ALPHA ADJ FETOPROTEIN$\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  10.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ALPHAFETOPROTEIN$\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  11.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BETA ADJ HUMAN ADJ CHORIONIC ADJ GONADOTROPIN\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 12.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PREGNANCY ADJ ASSOCIATED ADJ PLASMA ADJ PROTEIN\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 13.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (UNCONJUGATED ADJ ESTRIOL OR UNCONJUGATED ADJ OESTRIOL).TI.\u00a0 \u00a0 14.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (UNCONJUGATED ADJ ESTRIOL OR UNCONJUGATED ADJ OESTRIOL).AB. \u00a0 15.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UE3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  16.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 INHIBIN\u2010A#.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 INHIBIN ADJ A\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ULTRASOUND\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  19.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 AMNIOCENTESIS\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  20.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CHORION\u2010VILLUS\u2010SAMPLING.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  21.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NASAL ADJ BONE\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  22.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 TRICUSPID ADJ REGURGITATION\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  23.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DUCTUS ADJ VENOSUS\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  24.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKER OR MARKERS\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  25.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SCREEN OR SCREENING\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  26.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DETECT OR DETECTING OR DETECTION\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  27.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 FALSE ADJ POSITIVE$\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  28.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 FALSE ADJ NEGATIVE$\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  29.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SENSITIVITY OR SENSITIVE OR SENSITIVITIES\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  30.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIFICITY OR SPECIFICITIES\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  31.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (DIAGNOSE OR DIAGNOSIS OR DIAGNOSTIC OR DIAGNOSTICS OR DIAGNOSES \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OR DIAGNOSED).TI.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  32.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (DIAGNOSE OR DIAGNOSIS OR DIAGNOSTIC OR DIAGNOSTICS OR DIAGNOSES \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OR DIAGNOSED).AB.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  33.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ROC.AB.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  34.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 AUC.AB.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  35.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 AREA\u2010UNDER\u2010THE\u2010CURVE.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  36.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ROC\u2010CURVE.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  37.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ACCURA$\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  38.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PREDICT$\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  39.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 REPRODUCIBILITY.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  40.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 REFERENCE ADJ VALUE$\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  41.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 REFERENCE\u2010VALUE.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  42.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 REFERENCE ADJ STANDARD$\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  43.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DOWN\u2010SYNDROME#.DE.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  44.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DOWN ADJ SYNDROME OR DOWNS ADJ SYNDROME\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 45.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 TRISOMY ADJ '21'\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  46.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MOSAICISM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  47.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ANEUPLOIDY\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  48.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ANTENATAL$ OR PRENATAL$ OR PREGNANCY OR PREGNANT OR TRIMESTER$ OR MATERNAL OR FETUS OR FOETUS OR FOETAL OR FETAL\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  49.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 42\u00a0 \u00a0  50.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 43 OR 44 OR 45 OR 46 OR 47\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  51.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 48 AND 49 AND 50\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  52.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 HUMAN=YES\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0  53.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 51 AND 52\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 ADJ = adjacent \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 AB = abstract TI = title\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 $ = truncation symbol\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DE = descriptor\u00a0 (similar to MeSH)  ******************************************************* CINAHL via OVID \u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010\u2010 1\u00a0\u00a0 \u00a0\u00a0exp Prenatal Diagnosis/ 2\u00a0\u00a0\u00a0\u00a0 nuchal translucency.mp. 3\u00a0\u00a0\u00a0\u00a0 pregnancy associated plasma protein.mp. 4\u00a0\u00a0\u00a0\u00a0 papp$.ti,ab. 5\u00a0\u00a0\u00a0\u00a0 exp Gonadotropins, chorionic/ 6\u00a0\u00a0\u00a0\u00a0 (b\u2010hcg or bhcg).mp. 7\u00a0\u00a0\u00a0\u00a0 human chorionic gonadotropin.mp. 8\u00a0 \u00a0\u00a0\u00a0exp alpha\u2010Fetoproteins/ 9\u00a0\u00a0\u00a0\u00a0 alphafetoprotein$.mp. 10 \u00a0\u00a0\u00a0\u00a0alpha\u2010fetoprotein$.mp. 11\u00a0\u00a0\u00a0\u00a0 afp.mp. 12\u00a0\u00a0\u00a0\u00a0 (unconjugated estriol or unconjugated oestriol).mp. 13\u00a0\u00a0\u00a0\u00a0 ue3.mp. 14\u00a0\u00a0\u00a0\u00a0 inhibin$.mp. 15\u00a0\u00a0\u00a0\u00a0 ultrasound.mp. 16\u00a0\u00a0\u00a0\u00a0 amniocentesis/ 17\u00a0\u00a0\u00a0\u00a0 chorion$ vill$ sampling.mp. 18\u00a0\u00a0 \u00a0\u00a0Chorionic Villi\u2010Sampling/ 19\u00a0\u00a0\u00a0\u00a0 nasal bone.mp. 20\u00a0\u00a0\u00a0\u00a0 tricuspid regurgitation.mp. 21\u00a0\u00a0\u00a0\u00a0 ductus venosus.mp. 22\u00a0\u00a0\u00a0\u00a0 marker$.mp. 23\u00a0\u00a0\u00a0\u00a0 screen$.mp. 24\u00a0\u00a0\u00a0\u00a0 detect$.mp. 25\u00a0\u00a0\u00a0\u00a0 accura$.mp. 26\u00a0\u00a0\u00a0\u00a0 predict$.mp. 27\u00a0\u00a0\u00a0\u00a0 ROC.mp. 28\u00a0\u00a0\u00a0\u00a0 ROC curve/ 29\u00a0\u00a0\u00a0\u00a0 AUC.mp. 30 \u00a0\u00a0\u00a0\u00a0\"area under curve\".mp. 31\u00a0\u00a0\u00a0\u00a0 exp false negative reactions/ or exp false positive reactions/ 32\u00a0\u00a0\u00a0\u00a0 (false positive$ or false negative$).mp. 33\u00a0\u00a0\u00a0\u00a0 likelihood ratio$.mp. 34\u00a0\u00a0\u00a0\u00a0 sensitiv$.mp. 35\u00a0\u00a0\u00a0\u00a0 specific$.mp. 36\u00a0\u00a0\u00a0\u00a0 diagnos$.ti,ab. 37\u00a0\u00a0\u00a0\u00a0 \"reproducibility of results\".mp. 38\u00a0\u00a0\u00a0\u00a0 reference value$.mp. 39\u00a0\u00a0\u00a0\u00a0 reference standard$.mp. 40\u00a0\u00a0\u00a0\u00a0 exp Down Syndrome/ 41\u00a0\u00a0\u00a0\u00a0 downs syndrome.mp. 42\u00a0\u00a0\u00a0\u00a0 down syndrome.mp. 43\u00a0\u00a0\u00a0\u00a0 trisomy 21.mp. 44\u00a0\u00a0\u00a0\u00a0 aneuploidy.mp. 45\u00a0\u00a0\u00a0\u00a0 mosaicism.mp. 46\u00a0\u00a0\u00a0\u00a0 (antenatal$ or prenatal$ or trimester$ or pregnan$ or fetus or foetus or fetal or foetal).mp.  47\u00a0\u00a0\u00a0\u00a0 or/1\u201039 48\u00a0\u00a0\u00a0\u00a0 or/40\u201045 49\u00a0\u00a0\u00a0\u00a0 47 and 48 and 46 ******************************************************* Search terms and instructions for Biosis \u00a0 The following search terms \u00a0were entered separately in standard search box (select \u2018Titles/subject/abstract\u2019 from the drop\u2010down box on the right of the search box).  \u00a0    \u201creference standard*\u201d   \u201creference value*\u201d   \u201creproducibility of results\u201d   diagnos*   sensitiv*   specific*   \u201clikelihood ratio*\u201d   \u201cfalse negative*   \u201cfalse positive\u201d   \u201carea under curve\u201d   ROC   AUC   predict*   detect*   marker*   screen*   accura*   \u201cductus venosus\u201d   \u201cnasal bone\u201d   \u201ctricuspid regurgitation\u201d   \u201cchorion* vill* sampling\u201d   amniocentesis   ultrasound   inhibin*   \u201cunconjugaed oestriol\u201d   \u201cunconjugated estriol\u201d   afp   \u201calpha fetoprotein*\u201d   alphafetoprotein*   \u201c bhcg\u201d   \u201chuman chorionic gonadotrophin\u201d   \u201cpapp a\u201d   \u201cpregnancy associated plasma protein\u201d   \u201cnuchal translucency\u201d   foetal   fetal   foetus   foetal   prenatal*   antenatal*   pregnan*   maternal*   \u201ctrisomy 21\u201d   mosaicism   \u201cdown* syndrome\u201d    The search then used the history function to combine terms: 1\u201034 \u2013 combine using OR 35 \u2013 42 \u2013 combine using OR 43 \u2013 45 \u2013 combine using OR The three sets were combined using AND \u00a0 \u00a0The combined search strategy had the form (((((((al: \"trisomy 21\") or (al: (mosaicism))) or (al: \"down* syndrome\"))) and (((((((((((((((((((((((((((((((((((al: \"reference standard*\") or (al: \"reference value*\")) or (al: \"reproducibility of results\")) or (al: (diagnos*))) or (al: (specific*))) or (al: (sensitiv*))) or (al: \"likelihood ratio*\")) or (al: \"false negative*\")) or (al: \"false positive*\")) or (al: \"area under curve\")) or (al: (auc))) or (al: (roc))) or (al: (predict*))) or (al: (accura*))) or (al: (detect*))) or (al: (screen*))) or (al: (marker*))) or (al: \"ductus venosus\")) or (al: \"tricuspid regurgitation\")) or (al: \"nasal bone\")) or (al: \"chorion* vill* sampling\")) or (al: (amniocentesis))) or (al: (ultrasound))) or (al: (inhibin*))) or (al: \"unconjugated oestriol\")) or (al: \"unconjugated estriol\")) or (al: (afp))) or (al: \"alpha feto protein*\")) or (al: \"alpha fetoprotein*\")) or (al: \"b hcg\")) or (al: \"human chorionic gonadotropin\")) or (al: \"papp a\")) or (al: \"pregnancy associated plasma protein\")) or (al: \"nuchal translucency\")))) and (((((((((al: (foetal)) or (al: (fetal))) or (al: (foetus))) or (al: (fetus))) or (al: (pregnan*))) or (al: (trimester*))) or (al: (prenatal*))) or (al: (antenatal*))))))  \u00a0 \u00a0******************************************************* \u00a0The Database of Abstracts of Reviews of Effectiveness (DARE), National Research Register and Health Services Research Projects in Progress database  \u00a0:    Down syndrome (MeSH)   down* next syndrome   trisomy   aneuploidy   mosaicism   OR/ 1\u20105    \u00a0******************************************************* MEDION (http://www.mediondatabase.nl/)  \u00a0 ICPC code for pregnancy \u2013 \u2018W\u2019. \u00a0******************************************************* The Database of Systematic Reviews and Meta\u2010Analyses in Laboratory Medicine \u2013 download the database to a .pdf file and search for the following terms separately:  \u00a0 Down Trisomy Aneuploidy Pregnant Pregnancy Pregnancies Mosaicism *******************************************************",
        "Appendix 2. Glossary of terms (adapted in part from the UK National Screening Committee Glossary)": "Abnormal ductus venosus flow velocity   The ductus venosus is a vessel in the fetus which allows oxygenated blood from the placenta to bypass the fetal liver and flow straight to the heart. In conditions such as Down\u2019s syndrome the pressure in this vessel can be abnormally high.      Absent nasal bone   Absence of the bone that forms the bridge of the nose, which may be detected at ultrasound scan during early pregnancy.      Affected individuals   Those individuals who are affected by the disorder for which they are being screened.     Amniocentesis   Amniocentesis is an invasive procedure which involves taking a small sample of the amniotic fluid (liquor) surrounding the baby, using a needle which goes through the abdominal wall into the uterus, and is usually performed after 15 weeks' gestation.      Chorionic villus sampling (CVS)   Chorionic villus sampling involves taking a sample of the placental tissue using a needle which goes through the abdominal wall and uterus or a cannula through the cervix. It is usually performed between 10 and 13 weeks' gestation.      Combined test   First trimester test (up to 13 + 6 weeks of pregnancy) based on combining nuchal translucency measurement with free beta\u2010hCG, pregnancy\u2010associated plasma protein A (PAPP\u2010A) and the woman\u2019s age.      Diagnostic accuracy   The amount of agreement between the information from the index test and the reference standard (see below).      Diagnostic test   A definitive test, performed after a positive screening test result that gives a diagnosis (i.e. yes or no).      Double test   Second trimester test (from 13 + 6 up to 24 weeks of pregnancy) based on the measurement of alpha\u2010fetoprotein (AFP), human chorionic gonadotrophin (hCG \u00df either free beta\u2010hCG or total hCG), together with the woman\u2019s age.      First trimester   Pregnancy from conception up to 13 weeks and 6 days.     Iatrogenic   A disease or condition in a patient occurring as a result of treatment.     Index test   A test or group of tests being evaluated in a systematic review.     Integrated test   Measurements performed at different times of pregnancy combined into a single test result. Unless otherwise specified, 'integrated test' refers to the combination of nuchal translucency measurement and PAPP\u2010A in the first trimester, with the quadruple test (see below) in the second.      Mosaicism   This is a condition in which person has some cells containing a normal number of chromosomes, and some containing an abnormal number.\u00a0The more abnormal cells there are, the greater the effect.      Multiple of the median (MOM)   The serum test concentration for a pregnant woman divided by the average (median) for unaffected pregnancies in a defined population at the same stage of pregnancy.      Quadruple test   Second trimester test (from 13 + 6 up to 24 weeks of pregnancy) based on the measurement of AFP, uE3, free beta\u2010hCG (or total hCG), and inhibin\u2010A together with the woman\u2019s age.      Reference Standard   The best available method for establishing the presence or absence of the target disease or condition.      Second trimester   Pregnancy from 14 weeks to 28 weeks' gestation.\u00a0Note that for the purposes of this Cochrane review, second trimester testing refers to the period of 14 to 24 weeks' gestation.      Tricuspid regurgitation   Leakiness of or backflow of blood through the tricuspid valve of the heart.\u00a0The tricuspid valve separates the upper and lower chambers of the right side of the heart.      Triple test   Second trimester test (from 14 up to 24 weeks of pregnancy) based on the measurement of AFP, unconjugated oestriol (uE3), and hCG (either total hCG or free beta\u2010hCG) together with the woman's age.      Trisomy   The presence of an extra chromosome resulting in three copies of a particular chromosome instead of the normal two.      Translocation   Part of one chromosome is broken off and attached to another chromosome.\u00a0This does not usually cause the individual any problems as they have a normal amount of chromosomes, but in an abnormal arrangement.\u00a0 It can be passed on as an extra chromosome to offspring, resulting in conditions such as Down's syndrome."
    }
}